Wright Medical Group NV (NASDAQ:WMGI) SVP Jonathan Wesley Porter sold 773 shares of Wright Medical Group stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $21.05, for a total value of $16,271.65. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
NASDAQ:WMGI opened at $22.28 on Thursday. The company has a quick ratio of 0.68, a current ratio of 0.91 and a debt-to-equity ratio of 0.80. Wright Medical Group NV has a 1-year low of $20.46 and a 1-year high of $32.86. The firm has a market capitalization of $2.74 billion, a price-to-earnings ratio of 240.33, a price-to-earnings-growth ratio of 8.89 and a beta of 0.69. The stock has a fifty day simple moving average of $25.76 and a 200 day simple moving average of $29.52.
Wright Medical Group (NASDAQ:WMGI) last released its quarterly earnings results on Wednesday, August 7th. The medical device company reported $0.02 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.01. Wright Medical Group had a positive return on equity of 1.38% and a negative net margin of 14.65%. The business had revenue of $229.73 million during the quarter, compared to analyst estimates of $233.04 million. During the same quarter last year, the company posted ($0.03) EPS. Wright Medical Group’s revenue for the quarter was up 11.8% on a year-over-year basis. Equities analysts predict that Wright Medical Group NV will post 0.16 earnings per share for the current year.
WMGI has been the topic of a number of research analyst reports. BMO Capital Markets lowered their target price on Wright Medical Group from $36.00 to $30.00 and set an “outperform” rating on the stock in a report on Thursday, August 8th. Oppenheimer decreased their price target on Wright Medical Group from $34.00 to $29.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Piper Jaffray Companies set a $27.00 price target on Wright Medical Group and gave the company a “buy” rating in a research report on Friday, August 16th. ValuEngine lowered Wright Medical Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 2nd. Finally, Bank of America lowered Wright Medical Group from a “buy” rating to a “neutral” rating and set a $25.00 price target for the company. in a research report on Friday, August 9th. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Wright Medical Group presently has a consensus rating of “Buy” and an average target price of $30.50.
About Wright Medical Group
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Featured Story: How to calculate the intrinsic value of a stock
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.